Acasă › Cancer pulmonar cu celule non-pătrate › Illinois › Evanston
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Evanston, IL
22 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Evanston (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- Illinois Cancer Specialists /ID# 274678, Niles · La 6 mi distanță
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
În curs de recrutareFaza 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · La 2 mi distanță
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · La 5 mi distanță
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
- și încă 1
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
În curs de recrutareFaza 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
În curs de recrutareFaza 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
În curs de recrutareFaza 3
- North Shore University Health System ( Site 4014), Evanston
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
În curs de recrutareFaza 3
- Illinois Cancer Specialists, Niles · La 6 mi distanță
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Illinois Cancer Specialists, Niles · La 6 mi distanță
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
În curs de recrutareFaza 3
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
În curs de recrutareFaza 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
În curs de recrutareFaza 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · La 6 mi distanță
- Advocate Medical Group Oncology, Park Ridge · La 8 mi distanță
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
În curs de recrutareStudiu observațional
- Orchard Healthcare Research Inc., Skokie · La 2 mi distanță
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Niles · La 6 mi distanță
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
În curs de recrutareFaza 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
În curs de recrutareFaza 2
- Advocate Aurora Health, Park Ridge · La 8 mi distanță
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · La 5 mi distanță
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
În curs de recrutareStudiu observațional
- Advocate Lutheran General Hospital, Park Ridge · La 8 mi distanță
GEMINI-NSCLC: NSCLC Biomarker Study
În curs de recrutareStudiu observațional
- Northwestern University, Evanston
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Evanston
- Cancer pulmonar19 studii
- Cancer de sân13 studii
- Obezitate12 studii
- Leucemie mieloasă acută11 studii
- Supraponderalitate10 studii
- Cancer colorectal10 studii
- Cancer (toate tipurile)9 studii
- Boala Crohn9 studii
- Colită ulcerativă9 studii
- Cancer de prostată9 studii
- Melanom8 studii
- Fibrilație atrială8 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.